LCI Lannett Company Inc

Lannett Co Inc develops, manufactures, packages, markets and distributes generic versions of branded pharmaceutical products. Its products include solid oral dosage forms, including oral solutions, nasal, topicals or parentarels.

As of 04/09/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/23/2001
Outstanding shares:  41,401,730
Average volume:  430,850
Market cap:   $204,938,564
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    516012101
ISIN:        US5160121019
Sedol:      2447694
Valuation   (See tab for details)
PE ratio:   -1.00
PB ratio:   1.51
PS ratio:   0.38
Return on equity:   -158.40%
Net income %:   -37.73%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy